L-696,229 specifically inhibits human immunodeficiency virus type 1 reverse transcriptase and possesses antiviral activity in vitro

• Published in: Antimicrobial Agents and Chemotherapy 1992-05, Vol.36 (5), p.1019-1023
• Main Authors: GOLDMAN, M. E, O'BRIEN, J. A, RUFFING, T. L, NUNBERG, J. H, SCHLEIF, W. A, QUINTERO, J. C, SIEGL, P. K. S, HOFFMAN, J. M, SMITH, A. M, EMINI, E. A
• Format: Article
• Language: English
• Subjects: Antibiotics. Antiinfectious agents. Antiparasitic agents; Antiviral agents; Benzoxazoles; Benzoxazoles - pharmacology; Biological and medical sciences; Cells, Cultured; Dideoxynucleotides; Dose-Response Relationship, Drug; HIV-1; HIV-1 - drug effects; HIV-1 - enzymology; human immunodeficiency virus 1; Medical sciences; Pharmacology. Drug treatments; Proteins; Proteins - pharmacology; Pyridones; Pyridones - pharmacology; Research Article; Reverse Transcriptase Inhibitors; Thymine Nucleotides - pharmacology; Zidovudine - analogs & derivatives; Zidovudine - pharmacology
• ISSN: 0066-4804; 1098-6596
• DOI: 10.1128/AAC.36.5.1019

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • [e-mail] Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC